Heartflow (NASDAQ:HTFL) CEO Sells $194,500.00 in Stock

Heartflow, Inc. (NASDAQ:HTFL) CEO John Farquhar sold 3,890 shares of the company’s stock in a transaction dated Friday, September 11th. The shares were sold at an average price of $50.00, for a total transaction of $194,500.00. Following the completion of the sale, the chief executive officer owned 321,914 shares in the company, valued at approximately $16,095,700. This trade represents a 1.19% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

• On Thursday, September 10th, John Farquhar sold 35,010 shares of Heartflow stock. The stock was sold at an average price of $46.42, for a total value of $1,625,164.20.
• On Friday, August 21st, John Farquhar sold 27,230 shares of Heartflow stock. The shares were sold at an average price of $50.00, for a total value of $1,361,500.00.
• On Tuesday, August 18th, John Farquhar sold 32,676 shares of Heartflow stock. The stock was sold at an average price of $45.00, for a total value of $1,470,420.00.
• On Friday, August 14th, John Farquhar sold 15,560 shares of Heartflow stock. The stock was sold at an average price of $39.06, for a total value of $607,773.60.
• On Monday, August 10th, John Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.31, for a total value of $638,730.22.
• On Friday, July 10th, John Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $27.75, for a total value of $626,095.50.
• On Wednesday, June 24th, John Farquhar sold 38,900 shares of Heartflow stock. The stock was sold at an average price of $35.00, for a total value of $1,361,500.00.

Heartflow Price Performance

Heartflow stock opened at $48.30 on Thursday. Heartflow, Inc. has a 12 month low of $20.13 and a 12 month high of $51.78. The company has a fifty day moving average price of $36.83 and a two-hundred day moving average price of $31.38. The company has a market cap of $4.20 billion and a PE ratio of -26.39.

Heartflow (NASDAQ:HTFL) last posted its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The company had revenue of $64.08 million for the quarter. The business’s quarterly revenue was up 47.7% on a year-over-year basis. Equities research analysts anticipate that Heartflow, Inc. will post -0.75 earnings per share for the current year.

Institutional Trading of Heartflow

A number of institutional investors have recently made changes to their positions in HTFL. XXEC Inc. acquired a new position in shares of Heartflow during the second quarter valued at approximately $2,524,764,000. Quantinno Capital Management LP acquired a new stake in Heartflow in the first quarter worth approximately $1,734,000. Sei Investments Co. lifted its position in Heartflow by 342.5% in the first quarter. Sei Investments Co. now owns 67,048 shares of the company’s stock worth $1,631,000 after purchasing an additional 51,895 shares during the period. Bank of New York Mellon Corp bought a new position in Heartflow during the 2nd quarter valued at $19,096,000. Finally, Handelsbanken Fonder AB acquired a new position in shares of Heartflow during the 2nd quarter valued at $910,000.

Heartflow News Summary

Here are the key news stories impacting Heartflow this week:

• Positive Sentiment: Heartflow’s latest quarterly results remain a fundamental positive: revenue increased 47.7% year over year to $64.08 million, while the $0.07-per-share loss was substantially better than the $0.22 loss analysts expected. Heartflow earnings information
• Positive Sentiment: Analyst sentiment is still broadly favorable, with a consensus “Moderate Buy” rating. UBS initiated coverage with a $55 price target, although the broader average target of $44.88 is below recent trading levels.
• Neutral Sentiment: Institutional interest has provided some support, including Squarepoint Ops increasing its position by 72% and several funds initiating new stakes during the second quarter.
• Negative Sentiment: CFO Vikram Verghese sold 34,975 shares for approximately $1.75 million between September 11 and September 15 at prices near $50. He still directly owns 179,528 shares, but the repeated sales reduce insider ownership and may concern momentum-focused investors. The transactions were conducted under a pre-arranged trading plan. CFO SEC filing
• Negative Sentiment: CEO John C.M. Farquhar sold 38,900 shares for roughly $1.82 million in transactions dated September 10–11. The sales occurred as Heartflow traded near its 52-week high, reinforcing concerns that executives are taking profits and likely contributing to the stock’s recent decline. Heartflow CEO share sale
• Negative Sentiment: Heartflow remains unprofitable, with a negative net margin and analysts expecting a full-year loss of approximately $0.75 per share. Its valuation and sharp rise above the 50-day and 200-day moving averages could increase sensitivity to profit-taking.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on HTFL shares. Weiss Ratings upgraded Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, August 7th. Freedom Capital raised Heartflow to a “strong-buy” rating in a report on Tuesday, June 30th. Benchmark restated a “buy” rating on shares of Heartflow in a research report on Friday, August 14th. Piper Sandler restated an “overweight” rating and set a $45.00 price objective (up from $38.00) on shares of Heartflow in a research note on Friday, August 14th. Finally, UBS Group began coverage on Heartflow in a research report on Wednesday, September 9th. They issued a “neutral” rating and a $55.00 target price on the stock. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Heartflow has an average rating of “Moderate Buy” and an average target price of $44.88.

Heartflow Company Profile

Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient’s coronary arteries.

The company’s primary offering, Heartflow Analysis, is designed to provide noninvasive estimates of fractional flow reserve derived from computed tomography (FFR^CT).